Literature DB >> 12878281

Oral contraceptives use and the risk of myocardial infarction: a meta-analysis.

Yousef S Khader1, Janet Rice, Lefante John, Osama Abueita.   

Abstract

This meta-analysis of oral contraceptive use in relation to myocardial infarction is based on 19 case-control studies and 4 cohort studies that met pre-stated inclusion criteria. A comprehensive literature search was performed using the MEDLINE computerized database (for studies from January 1966 through October 2002). In addition, a manual search was performed for references cited in published original and reviewed articles. Current oral contraceptive (OC) users have an overall adjusted odds ratio (OR) of myocardial infarction (MI) of 2.48 [95% confidence interval (CI): 1.91-3.22] compared to never-users. The risk of MI for past OC users is not significantly different from that for never-users, overall OR = 1.15 (95% CI: 0.98-1.35; p = 0.096).

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12878281     DOI： 10.1016/s0010-7824(03)00073-8

Source DB:  PubMed          Journal:  Contraception        ISSN： 0010-7824            Impact factor:   3.375


  27 in total

Review 1.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

Review 2.  Contraception in women over 40 years of age.

Authors:  Rebecca H Allen; Carrie A Cwiak; Andrew M Kaunitz
Journal:  CMAJ       Date:  2013-03-04       Impact factor: 8.262

Review 3.  Contraception in women with medical problems.

Authors:  Mandish K Dhanjal
Journal:  Obstet Med       Date:  2008-12-01

4.  Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.

Authors:  Daniel Grossman; Kari White; Kristine Hopkins; Jon Amastae; Michele Shedlin; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2011-03       Impact factor: 7.661

5.  Clinic versus over-the-counter access to oral contraception: choices women make along the US-Mexico border.

Authors:  Joseph E Potter; Kari White; Kristine Hopkins; Jon Amastae; Daniel Grossman
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

6.  A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.

Authors:  Jessica R Meendering; Britta N Torgrimson; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Contraception       Date:  2010-04-27       Impact factor: 3.375

Review 7.  Identification and management of familial hypercholesterolaemia: what does it mean to primary care?

Authors:  Nadeem Qureshi; Steve E Humphries; Mary Seed; Philip Rowlands; Rubin Minhas
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

8.  Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome.

Authors:  Miriam A Bredella; Shilpa McManus; Madhusmita Misra
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-01       Impact factor: 3.478

Review 9.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

Review 10.  Epidemiology of cardiovascular disease in young individuals.

Authors:  Charlotte Andersson; Ramachandran S Vasan
Journal:  Nat Rev Cardiol       Date:  2017-10-12       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.